A detailed history of Simplex Trading, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Simplex Trading, LLC holds 35,636 shares of BNTX stock, worth $4.23 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
35,636
Previous 5,665 529.06%
Holding current value
$4.23 Million
Previous $522,000 448.47%
% of portfolio
0.1%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$80.36 - $102.87 $2.41 Million - $3.08 Million
29,971 Added 529.06%
35,636 $2.86 Million
Q1 2024

Apr 25, 2024

BUY
$88.96 - $112.35 $503,958 - $636,462
5,665 New
5,665 $522,000
Q3 2023

Nov 01, 2023

BUY
$98.5 - $125.08 $6.22 Million - $7.9 Million
63,186 Added 902657.12%
63,193 $6.87 Million
Q1 2023

Apr 27, 2023

SELL
$122.57 - $153.67 $818,277 - $1.03 Million
-6,676 Reduced 99.9%
7 $0
Q4 2022

Feb 02, 2023

BUY
$118.43 - $186.05 $790,638 - $1.24 Million
6,676 Added 95371.43%
6,683 $1 Million
Q3 2022

Nov 04, 2022

SELL
$127.65 - $183.11 $1.55 Million - $2.22 Million
-12,106 Reduced 99.94%
7 $0
Q2 2022

Aug 03, 2022

SELL
$123.25 - $186.24 $1.19 Million - $1.8 Million
-9,652 Reduced 44.35%
12,113 $1.81 Million
Q1 2022

May 02, 2022

BUY
$126.25 - $231.85 $960,636 - $1.76 Million
7,609 Added 53.75%
21,765 $3.71 Million
Q4 2021

Feb 23, 2022

BUY
$216.64 - $362.52 $935,234 - $1.56 Million
4,317 Added 43.88%
14,156 $3.65 Million
Q3 2021

Oct 28, 2021

SELL
$205.93 - $447.23 $216,432 - $470,038
-1,051 Reduced 9.65%
9,839 $2.2 Million
Q2 2021

Aug 12, 2021

BUY
$113.32 - $241.49 $1.23 Million - $2.63 Million
10,890 New
10,890 $2.44 Million
Q1 2021

Apr 26, 2021

SELL
$85.73 - $119.5 $2.17 Million - $3.03 Million
-25,369 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$72.71 - $129.54 $1.84 Million - $3.29 Million
25,369 New
25,369 $2.07 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.